Hodgkin’s lymphoma – Asian Scientist Magazine

hodgkins lymphoma

China Approves Tyvyt For Hodgkin’s Lymphoma

Sintilimab, a fully human anti-PD-1 therapeutic monoclonal antibody, was co-discovered by Innovent and Adimab and jointly developed by Innovent and Eli Lilly in China.

Pharma

Takeda’s ADCETRIS® Approved For Lymphoma Treatment In Japan

Takeda's ADCETRIS® has been approved for the treatment of patients with certain types of lymphoma in Japan.

EDITOR’S PICK

Nutrition Gets Personal

As more people in Asia use tech to closely regulate what they eat, personalized nutrition is becoming a new normal in the region.
Flag-Bearers Of Innovation

Over the past decade, the National Supercomputing Centre (NSCC) Singapore and collaborators have led the charge in developing supercomputing-powered innovations to support Singapore’s research and development ecosystem.
Golden Connections

Today’s connectivity technologies are helping older people in Asia stay socially active and take charge of their own wellbeing.

China Approves Tyvyt For Hodgkin’s Lymphoma

Takeda’s ADCETRIS® Approved For Lymphoma Treatment In Japan

EDITOR’S PICK

Nutrition Gets Personal

Flag-Bearers Of Innovation

Golden Connections